Tenax Therapeutics (TENX) Prepaid Assets (2011 - 2026)
Tenax Therapeutics recorded quarterly Prepaid Assets of $107000.0 in Q1 2026, down 98.1% quarter-over-quarter from $5.6 million in Q4 2025, and down 79.58% year-over-year from $524000.0 in Q1 2025.
Tenax Therapeutics' Prepaid Assets history runs 15 years deep, the most recent figure standing at $107000.0 for Q1 2026.
- In Q1 2026, Prepaid Assets fell 79.58% year-over-year to $107000.0; the TTM figure through Mar 2026 stood at $107000.0 (down 79.58% YoY), while the FY2025 annual figure was $5.6 million, up 8717.19% from the prior year.
- Prepaid Assets came in at $107000.0 for Q1 2026 at Tenax Therapeutics, down from $5.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $5.6 million in Q4 2025 to a low of $64000.0 in Q4 2024.
- A 5-year average of $1.1 million and a median of $586987.0 in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets plunged 96.1% in 2024 and jumped 8717.19% in 2025, its largest moves.
- Tenax Therapeutics' Prepaid Assets stood at $738927.0 in 2022, then surged by 121.94% to $1.6 million in 2023, then slumped by 96.1% to $64000.0 in 2024, then surged by 8717.19% to $5.6 million in 2025, then slumped by 98.1% to $107000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $107000.0, $5.6 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | 5.64 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 395,000.00 |
| Mar 31, 2025 | 524,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 66,625.00 |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 267,084.00 |
| Jun 30, 2023 | 282,583.00 |
| Mar 31, 2023 | 304,583.00 |
| Dec 31, 2022 | 738,927.00 |
| Sep 30, 2022 | 707,194.00 |
| Jun 30, 2022 | 872,363.00 |
| Mar 31, 2022 | 586,987.00 |
| Sep 30, 2021 | 229,152.00 |
| Jun 30, 2021 | 349,862.00 |
| Mar 31, 2021 | 485,935.00 |
| Dec 31, 2020 | 82,578.00 |
| Sep 30, 2020 | 189,275.00 |
| Jun 30, 2020 | 660,906.00 |
| Mar 31, 2020 | 941,144.00 |
| Dec 31, 2019 | 780,952.00 |
| Sep 30, 2019 | 434,390.00 |
| Jun 30, 2019 | 515,526.00 |
| Mar 31, 2019 | 367,129.00 |
| Dec 31, 2018 | 458,286.00 |
| Sep 30, 2018 | 284,857.00 |
| Jun 30, 2018 | 263,270.00 |
| Mar 31, 2018 | 336,540.00 |
| Dec 31, 2017 | 285,512.00 |
| Sep 30, 2017 | 103,960.00 |
| Jun 30, 2017 | 176,326.00 |
| Mar 31, 2017 | 239,360.00 |
| Dec 31, 2016 | 275,005.00 |
| Sep 30, 2016 | 116,201.00 |
| Jun 30, 2016 | 198,848.00 |
| Dec 31, 2015 | 321,958.00 |
| Apr 30, 2013 | 247,646.00 |
| Jan 31, 2013 | 272,713.00 |
| Oct 31, 2012 | 291,359.00 |
| Jul 31, 2012 | 399,374.00 |
| Apr 30, 2012 | 455,946.00 |
| Jan 31, 2012 | 206,468.00 |
| Oct 31, 2011 | 106,983.00 |
| Jul 31, 2011 | 139,304.00 |
| Apr 30, 2011 | 275,876.00 |